
Veana Therapeutics
Operator of an early clinical-stage company intended to develop oral mitochondrial inhibitors for treating various cancers. The company offers a safe and effective oral therapeutic intended to kill ca...
Valuation
$0
Share Price
N/A
Total Raised
$12.6M
Last Round
N/A